Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

WRP Corp.

This article was originally published in The Gray Sheet

Executive Summary

Disposable medical glove maker submits appeal of Nasdaq delisting notice, to be effective May 11. The firm did not sustain compliance with Nasdaq's minimum bid requirement of $1.00 within a 90-day grace period set forth in a Feb. 2 notice. Once Nasdaq receives WRP's request for a hearing, the request "will automatically defer" the delisting until Nasdaq's hearing panel makes a ruling, WRP explains. Itasca, Illinois-based WRP "will be presenting its business plan to the hearing panel and will seek to put in place steps to avoid delisting prior to any delisting of its shares"

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014884

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel